CN113521136A - Composition for skin whitening and wrinkle removal - Google Patents

Composition for skin whitening and wrinkle removal Download PDF

Info

Publication number
CN113521136A
CN113521136A CN202110891876.XA CN202110891876A CN113521136A CN 113521136 A CN113521136 A CN 113521136A CN 202110891876 A CN202110891876 A CN 202110891876A CN 113521136 A CN113521136 A CN 113521136A
Authority
CN
China
Prior art keywords
parts
powder
concentrated
skin
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110891876.XA
Other languages
Chinese (zh)
Inventor
梁山露
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Kaida Biotechnology Co ltd
Original Assignee
Shanghai Kaida Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Kaida Biotechnology Co ltd filed Critical Shanghai Kaida Biotechnology Co ltd
Priority to CN202110891876.XA priority Critical patent/CN113521136A/en
Publication of CN113521136A publication Critical patent/CN113521136A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/42Cucurbitaceae (Cucumber family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • A61K36/064Saccharomycetales, e.g. baker's yeast
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736Prunus, e.g. plum, cherry, peach, apricot or almond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/87Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a composition useful for skin whitening and wrinkle reduction. The beverage comprises, by weight, 5.2-42 parts of concentrated melon powder, 10-25 parts of zinc-rich yeast powder, 0-10 parts of acerola powder, 0-10 parts of sea buckthorn fruit powder, 0-5 parts of concentrated acerola berry juice powder, 0-5 parts of liquorice, 0-5 parts of lycopene and 30-66 parts of auxiliary materials; the adjuvants are more than one of isomalt, sorbitol, microcrystalline cellulose, silicon dioxide, and magnesium stearate.

Description

Composition for skin whitening and wrinkle removal
The technical field is as follows:
the present invention relates to a composition useful for skin whitening and wrinkle reduction.
Background art:
in recent years, under the promotion of 'economy of color value', the types of skin care, color cosmetics, oral beauty and the like related to the color value are increasingly concerned by consumers, and the trillion-level consumption increase of related markets is driven.
In Asian market, "white" always ranks first, "whitening" always is the invariable subject in the beauty market, possessing enormous market demand. The traditional whitening modes such as physical masking, frosting and exfoliating, fruit acid corrosion and the like are difficult to gain market increment, particularly some whitening skin care products adopting chemical substances such as mercury salt with whitening effect, hydroquinone with freckle removing effect and the like can rapidly become white in a short period, but the long-term use can cause contact dermatitis or permanent decoloration and other adverse effects, the use of the whitening skin care products is forbidden in many countries, the safe and effective oral beauty market is emphasized, and the future development potential is huge.
The mainstream solutions in the market at present are in the directions of medical beauty, skin care product use, oral administration and the like. Because some apparatuses and intervention methods used in medicine and beauty may have some damages to human body, and the cost is high, the audiences are few, and the skin care product can only improve the skin condition from the surface, and has very limited effect on the deep nutrition of the skin.
According to the data of intelligent research and consultation, the consumption acceleration rate of the oral beautifying is far higher than the average acceleration rate of various types on the line, the consumption number and the average consumption amount of people for the on-line oral beautifying in recent years are increased year by year, and the consumers have great demands on the oral beautifying and whitening products.
In spite of the current development state of the oral beauty industry, collagen occupies most markets, but is still in the category of' reinforcing the skin, can only play some functions of partially improving wrinkles, and lacks a mature scheme of integrated oral beauty. Therefore, the development of a product which has the functions of whitening, removing wrinkles and improving skin health is urgently needed.
The invention content is as follows:
the invention aims at the problems, provides a composition which is beneficial to skin whitening and wrinkle removal, and aims to develop a product which can be orally taken to whiten and effectively remove wrinkles, promote the synthesis of collagen fibers, improve the elasticity of skin, inhibit the activity of tyrosinase and improve the brightness of the skin.
In order to achieve the purpose, the invention adopts the following technical scheme, and the components and parts by weight of the invention are 5.2-42 parts of concentrated muskmelon powder, 10-25 parts of zinc-rich yeast powder, 0-10 parts of acerola cherry powder, 0-10 parts of sea buckthorn fruit powder, 0-5 parts of concentrated prunus wilsonii juice powder, 0-5 parts of liquorice, 0-5 parts of lycopene and 30-66 parts of auxiliary materials;
the adjuvants are more than one of isomalt, sorbitol, microcrystalline cellulose, silicon dioxide, and magnesium stearate.
In the concentrated muskmelon powder, 5-30 parts of grape seed extract, 0.1-6 parts of concentrated muskmelon powder and 0.1-6 parts of vitamin C are contained.
During processing, the components are mixed and stirred uniformly, and tabletting is directly carried out, wherein the weight of each tablet is 300-800 mg, so that a semi-finished product is obtained. And (5) filling the semi-finished product into a PET bottle, and sealing and storing to obtain a final finished product. The final product can be directly administered orally.
The invention has the beneficial effects that:
the invention adopts a formula integrating full effects, has various effects of whitening, resisting wrinkles and the like, and can promote the synthesis of endogenous collagen and skin lightening.
The grape seed extract contains abundant polyphenol and flavone components, has tyrosinase activity inhibiting effect, can block melanin formation in skin, and inhibit collagen hydrolase activity in vivo, thereby reducing collagen loss and inhibiting formation of fine wrinkles.
The concentrated melon powder contains superoxide dismutase (SOD), is helpful for removing free radicals in skin and purifying melanin, and can improve skin whiteness, and after being compounded with grape seed extract, the concentrated melon powder can also improve the crosslinking degree of collagen fiber, thereby improving skin elasticity. Therefore, the composition of the grape seed extract and the melon concentrated powder can play a synergistic role, on one hand, the brightness of the skin is improved, on the other hand, the elasticity of the skin is improved, and fine wrinkles are reduced.
The vitamin C can promote the synthesis of collagen, the formed collagen cannot be separated from a core substance hydroxyproline, and the grape seed extract can promote human fibroblasts to synthesize hydroxyproline, so that the collagen synthesis efficiency of the vitamin C is improved. Therefore, the compounding of the vitamin C and the grape seed extract can strengthen the synthesis of collagen fiber, and is superior to the single effect of the vitamin C.
The specific implementation mode is as follows:
example 1
13.4kg of Shikeaishi muskmelon concentrated powder (containing 10kg of grape seed extract, 1.7kg of muskmelon concentrated powder and 1.7kg of vitamin C), 10kg of zinc-rich yeast powder, 1kg of acerola powder, 1kg of sea buckthorn fruit powder, 1kg of wild cherry concentrated juice powder, 1kg of liquorice, 1kg of lycopene, 15kg of sorbitol, 16.3kg of microcrystalline cellulose and 0.3kg of magnesium stearate are mixed and stirred uniformly, and directly tabletted, wherein the weight of each tablet is 400mg, so that a semi-finished product is obtained. And (5) filling the semi-finished product into a PET bottle, and sealing and storing to obtain a final finished product.
Example 2 human fibroblast in vitro culture experiment
All test solutions were prepared in the presence of S9 (an enzyme-containing liver extract) and S9 was prepared from rat liver by homogenizing, low temperature centrifuging and collecting supernatant, and the protein concentration was 20mg/ml as determined by Coomassie Brilliant blue method, and the solution had multiple activating substrates and could simulate liver metabolism. The oral tablet prepared in example 1 was formulated with the S9 solution to 550. mu.g/mL for use as a efficacy group. And preparing 100 mu M vitamin C solution as VC (with the same VC content as the functional group) for later use.
The human fibroblast culture medium in a standard state is taken and added with a control group (S9 solution), a VC group and an efficacy group solution respectively for culture. The amount of type I collagen matrix (ECM) expression was measured by fluorescence imaging.
Compared with the collagen matrix expression quantity before culture, the collagen matrix expression quantity of the control fibroblast is increased by 39 ng/mu g, the collagen matrix expression quantity of the VC group is increased by 164 ng/mu g, the collagen expression quantity of the efficacy group is increased by 219 ng/mu g, the collagen expression quantity of the efficacy group is increased by 462 percent relative to the control group, and the collagen expression quantity of the efficacy group is increased by 34 percent relative to the VC group.
Example 3 human testing
20 women of 40-70 years old were selected, and the face complexion, fine wrinkles, mottle, dark circles and the like were recorded, and 1 tablet of the oral tablet prepared in example 1 was taken daily for 8 weeks.
The skin improvement of the subjects was observed after 8 weeks, wherein the skin brightness was increased by an average of 25.9%, the age spots were reduced by 19.2%, the dark circles were reduced by 19.2%, and the skin wrinkles were reduced by 11.7%. The composition has skin whitening, wrinkle removing and speckle reducing effects.

Claims (2)

1. The composition is characterized by comprising, by weight, 5.2-42 parts of concentrated melon powder, 10-25 parts of zinc-rich yeast powder, 0-10 parts of acerola cherry powder, 0-10 parts of sea buckthorn fruit powder, 0-5 parts of concentrated wild cherry juice powder, 0-5 parts of liquorice, 0-5 parts of lycopene and 30-66 parts of auxiliary materials;
the adjuvants are more than one of isomalt, sorbitol, microcrystalline cellulose, silicon dioxide, and magnesium stearate.
2. The composition for skin whitening and wrinkle removal as claimed in claim 1, wherein the concentrated powder of melon comprises 5-30 parts of grape seed extract, 0.1-6 parts of concentrated powder of melon, and 0.1-6 parts of vitamin C.
CN202110891876.XA 2021-08-04 2021-08-04 Composition for skin whitening and wrinkle removal Pending CN113521136A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110891876.XA CN113521136A (en) 2021-08-04 2021-08-04 Composition for skin whitening and wrinkle removal

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110891876.XA CN113521136A (en) 2021-08-04 2021-08-04 Composition for skin whitening and wrinkle removal

Publications (1)

Publication Number Publication Date
CN113521136A true CN113521136A (en) 2021-10-22

Family

ID=78090390

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110891876.XA Pending CN113521136A (en) 2021-08-04 2021-08-04 Composition for skin whitening and wrinkle removal

Country Status (1)

Country Link
CN (1) CN113521136A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114601006A (en) * 2022-01-28 2022-06-10 广州市诺品健康科技有限公司 Whitening tablet candy and preparation method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107669731A (en) * 2017-11-21 2018-02-09 汤臣倍健股份有限公司 A kind of skin care compositions and its application, health products
CN109527322A (en) * 2018-12-21 2019-03-29 浙江尖峰健康科技有限公司 A kind of solid beverage and preparation method thereof with fair skin function
CN110192994A (en) * 2019-06-25 2019-09-03 昆仑技术研究(广州)有限公司 A kind of white tomato whitening piece and preparation method thereof
CN111053233A (en) * 2019-12-30 2020-04-24 广州市中食科康保健食品有限公司 Functional food for whitening skin and preventing sunburn and preparation method thereof
CN112237284A (en) * 2019-07-19 2021-01-19 百岳特生物技术(上海)有限公司 Application of wild cherry juice in inhibiting skin aging

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107669731A (en) * 2017-11-21 2018-02-09 汤臣倍健股份有限公司 A kind of skin care compositions and its application, health products
CN109527322A (en) * 2018-12-21 2019-03-29 浙江尖峰健康科技有限公司 A kind of solid beverage and preparation method thereof with fair skin function
CN110192994A (en) * 2019-06-25 2019-09-03 昆仑技术研究(广州)有限公司 A kind of white tomato whitening piece and preparation method thereof
CN112237284A (en) * 2019-07-19 2021-01-19 百岳特生物技术(上海)有限公司 Application of wild cherry juice in inhibiting skin aging
CN111053233A (en) * 2019-12-30 2020-04-24 广州市中食科康保健食品有限公司 Functional food for whitening skin and preventing sunburn and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
胥鑫萌等: "原花青素在化妆品中的应用", 《中国洗涤用品工业》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114601006A (en) * 2022-01-28 2022-06-10 广州市诺品健康科技有限公司 Whitening tablet candy and preparation method thereof

Similar Documents

Publication Publication Date Title
US8647610B2 (en) Use of melanin biosynthesis inhibitors from korean ginseng and the cosmetic composition containing thereof for skin whitening
KR100783063B1 (en) Functional Cosmetic Composition Comprising oryzae Extract
US11213472B2 (en) VEGFC production promoter
CN114712258A (en) Cosmetic composition with full-effect whitening, anti-aging and repairing effects
CN102908285A (en) Pure natural royal jelly whitening and spot-removing pollen cream and production method thereof
CN113521136A (en) Composition for skin whitening and wrinkle removal
TW202106319A (en) Use of protea plant extract for skin anti-aging
CN114099366B (en) Sterile anti-aging wrinkle-removing combined liquid for promoting cell energy metabolism and preparation method and application thereof
TWI809300B (en) Use of ilex latifolia thunb extract
CN112545970B (en) Pearl cream for beauty and skin care and preparation method thereof
CN112386547B (en) Skin health care application of pineapple extract
CN113633585B (en) External hair care composition and preparation with effects of preventing alopecia, promoting hair growth and blackening hair and preparation method thereof
CN107669607A (en) A kind of facial mask and preparation method thereof
EP3763225A1 (en) Black rice extract ferments and the preparation methods and applications thereof
JPH06329545A (en) Hyaluronidase inhibitor containing galenical extract as active ingredient
CN112263540A (en) Whitening composition and preparation method and application thereof
CN114128893A (en) Composition containing nicotinamide and glutathione and application thereof
CN110585039A (en) Cosmetic composition containing dendrobium nobile fermentation extract and preparation method and application thereof
TWI801738B (en) Use of seed coat extracts of fagopyrum tataricum for reducing the loss of elastin
TWI772986B (en) Use of mosla chinensis maxim. extract for improving skin appearance
CN114376960B (en) Pearl cream and preparation method thereof
TWI813400B (en) Use of versailles gooseberry extract for improving skin condition
TWI774168B (en) Morus alba ferment, manufacturing method thereof and use thereof
KR20030071893A (en) Water soluble whitening composition and cosmetic composition for whitening skin comprising the same
TWI484918B (en) Method of preparing a muscadine pomace extract

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination